Table 3. Polyp and adenoma detection analysis.
| EC# | SC# | p-Value | |
| Polyp detection rate, N (%) | 138 (55.4) | 93 (38.4) | <0.0001 |
| Polyps per patient, median [IQR]* | 2 [1]–[3] | 1 [1]–[3] | 0.250 |
| Polyp by size analysis, N (%) | |||
| ≥1 cm | 40 (12.8) | 17 (9) | 0.005 |
| <1 cm | 272 (87.2) | 172 (91) | <0.0001 |
| Polyp by morphology analysis, N (%) | |||
| Sessile | 250 (80.1) | 145 (76.7) | <0.0001 |
| Flat | 48 (15.4) | 33 (17.4) | 0.072 |
| Pedunculated | 14 (4.5) | 11 (5.9) | 0.275 |
| Adenoma detection rate (ADR), N (%) | 87 (35.4) | 50 (20.7) | <0.0001 |
| Number of adenomas (LGIN), N (%) | 138 (93) | 87 (99) | 0.002 |
| Number of adenomas (HGIN), N (%) | 6 (4) | 1 (1) | 0.061 |
| Number of carcinomas, N (%) | 5 (3) | 0 (0) | 0.061 |
| Adenomas per patient, median [IQR]* | 1 [1]–[2] | 1 [1]–[3] | 0.851 |
| Hyperplastic Polyp detection rate, N (%) | 71 (28.7) | 51 (21.2) | 0.053 |
| Hyperplastic polyps per patient, median [IQR]* | 1 [0–2] | 1 [0–1] | 0.922 |
*only patients considered in whom at least one adenoma or polyp, respectively were detected.
#
3 polyps (EC) and two polyps (SC) not retrieved endoscopically.